BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Equibles//Investor Events//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
NAME:Biogen Inc. (BIIB) investor events
X-WR-CALNAME:Biogen Inc. (BIIB) investor events
DESCRIPTION:Earnings calls and investor events for Biogen Inc. (BIIB)\, fro
 m Equibles.
X-WR-CALDESC:Earnings calls and investor events for Biogen Inc. (BIIB)\, fr
 om Equibles.
REFRESH-INTERVAL;VALUE=DURATION:PT6H
X-PUBLISHED-TTL:PT6H
BEGIN:VEVENT
UID:e6c54628-86ef-4f15-8bcf-edb88d7f60b0@equibles.com
DTSTAMP:20260702T174548Z
DTSTART:20251203T163000Z
DTEND:20251203T173000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen Participating in the Piper Sa
 ndler 37th Annual Healthcare Conference
DESCRIPTION:Biogen Participating in the Piper Sandler 37th Annual Healthcar
 e Conference\nWebcast: https://event.webcasts.com/starthere.jsp?ei=1743310
 &tp_key=c403507f80
END:VEVENT
BEGIN:VEVENT
UID:dc2f1ec5-3551-415b-973a-8e036f8bf840@equibles.com
DTSTAMP:20260702T174548Z
DTSTART:20260112T213000Z
DTEND:20260112T223000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Present at the 44th Annual
  J.P. Morgan Healthcare Conference
DESCRIPTION:Biogen to Present at the 44th Annual J.P. Morgan Healthcare Con
 ference\nWebcast: https://www.veracast.com/webcasts/clients/webcasts/9i25e
 5.cfm
URL:https://equibles.com/stocks/biib/events/dc2f1ec5-3551-415b-973a-8e036f8
 bf840
END:VEVENT
BEGIN:VEVENT
UID:af2bcae9-e7cf-43c5-8e46-bc6b4a02ea40@equibles.com
DTSTAMP:20260611T102614Z
DTSTART:20260206T133000Z
DTEND:20260206T143000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Earnings Call\, FY2025 Q4
DESCRIPTION:Webcast: https://event.webcasts.com/starthere.jsp?ei=1742560&tp
 _key=4fee97f311
URL:https://equibles.com/stocks/biib/calls/2025-q4
END:VEVENT
BEGIN:VEVENT
UID:491d671c-c8be-4755-89c2-0a47c648186b@equibles.com
DTSTAMP:20260702T174548Z
DTSTART:20260302T141000Z
DTEND:20260302T151000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Participate in the TD Cowe
 n 46th Annual Health Care Conference
DESCRIPTION:Biogen to Participate in the TD Cowen 46th Annual Health Care C
 onference\nWebcast: https://event.summitcast.com/view/9z5g2VrV6e6rbCqQgDRo
 HA/BbAVLXe3hzrVgZr7ugVE3U
END:VEVENT
BEGIN:VEVENT
UID:3c3d7c17-e366-49c7-a714-d1bdca78658d@equibles.com
DTSTAMP:20260702T174548Z
DTSTART:20260310T170000Z
DTEND:20260310T180000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Participate in the Leerink
  Global Health Care Conference
DESCRIPTION:Biogen to Participate in the Leerink Global Health Care Confere
 nce\nWebcast: https://event.summitcast.com/view/mT9poctHDNthc6b89WqVjf/UEb
 AoBe7bRZD3LCYG2JX72
END:VEVENT
BEGIN:VEVENT
UID:334015e4-4fc3-4d85-8ae6-bba029605426@equibles.com
DTSTAMP:20260617T190812Z
DTSTART;VALUE=DATE:20260429
DTEND;VALUE=DATE:20260430
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Earnings Call\, FY2026 Q1
DESCRIPTION:The start time has not been announced.\nWebcast: https://event.
 webcasts.com/starthere.jsp?ei=1756204&tp_key=3f1faf4a2a
URL:https://equibles.com/stocks/biib/calls/2026-q1
END:VEVENT
BEGIN:VEVENT
UID:a62ae611-2a37-4c39-9c85-44d0d7f6ea26@equibles.com
DTSTAMP:20261022T053936Z
DTSTART:20260513T180000Z
DTEND:20260513T190000Z
SEQUENCE:25421976
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Present at the Bank of Ame
 rica Securities 2026 Health Care Conference
DESCRIPTION:Biogen to Present at the Bank of America Securities 2026 Health
  Care Conference\nWebcast: https://bofa.veracast.com/webcasts/bofa/healthc
 are2026/idLa74k5.cfm
URL:https://equibles.com/stocks/biib/events/a62ae611-2a37-4c39-9c85-44d0d7f
 6ea26
END:VEVENT
BEGIN:VEVENT
UID:057cee09-ffcc-4399-823b-fcaa4254ca6c@equibles.com
DTSTAMP:20260702T174548Z
DTSTART:20260609T130000Z
DTEND:20260609T140000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Annual General Meeting: Biogen Annual Stockholde
 r Meeting
DESCRIPTION:Biogen Annual Stockholder Meeting\nWebcast: https://event.webca
 sts.com/event.jsp\;autoplay
END:VEVENT
BEGIN:VEVENT
UID:a92a28c4-3653-4058-a474-1dc60a71d03c@equibles.com
DTSTAMP:20260707T150622Z
DTSTART;VALUE=DATE:20260707
DTEND;VALUE=DATE:20260708
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Webcast from the Alzheimer
 's Association International Conference (AAIC) July 14\, 2026
DESCRIPTION:Biogen to Webcast from the Alzheimer's Association Internationa
 l Conference (AAIC) July 14\, 2026\nThe start time has not been announced.
 \nWebcast: https://investors.biogen.com/news-releases/news-release-details
 /biogen-webcast-alzheimers-association-international-conference
URL:https://equibles.com/stocks/biib/events/a92a28c4-3653-4058-a474-1dc60a7
 1d03c
END:VEVENT
BEGIN:VEVENT
UID:a380f03b-aed9-4fd1-bb31-bd175d9213ac@equibles.com
DTSTAMP:20260713T024056Z
DTSTART;VALUE=DATE:20260712
DTEND;VALUE=DATE:20260713
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: LEQEMBI® Subcutaneous Autoinjector 
 Clinical Data Supports Similar Efficacy and Safety to IV Formulation in Ea
 rly Alzheimer’s Disease Presented at the Alzheimer’s Association Inter
 national Conference® (AAIC®) 2026
DESCRIPTION:LEQEMBI® Subcutaneous Autoinjector Clinical Data Supports Simi
 lar Efficacy and Safety to IV Formulation in Early Alzheimer’s Disease P
 resented at the Alzheimer’s Association International Conference® (AAIC
 ®) 2026\nThe start time has not been announced.\nWebcast: https://investo
 rs.biogen.com/news-releases/news-release-details/leqembir-subcutaneous-aut
 oinjector-clinical-data-supports
URL:https://equibles.com/stocks/biib/events/a380f03b-aed9-4fd1-bb31-bd175d9
 213ac
END:VEVENT
BEGIN:VEVENT
UID:abeec998-50ec-47de-8a53-c2d0e9d53d13@equibles.com
DTSTAMP:20260707T150621Z
DTSTART:20260714T160000Z
DTEND:20260714T170000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen at the Alzheimer's Associatio
 n International Conference (AAIC) 2026
DESCRIPTION:Biogen at the Alzheimer's Association International Conference 
 (AAIC) 2026\nWebcast: https://event.webcasts.com/starthere.jsp?ei=1769180&
 tp_key=8f46200df4
URL:https://equibles.com/stocks/biib/events/abeec998-50ec-47de-8a53-c2d0e9d
 53d13
END:VEVENT
BEGIN:VEVENT
UID:320d93a0-a06f-4b3d-bbe4-61238b952c09@equibles.com
DTSTAMP:20260702T054338Z
DTSTART;VALUE=DATE:20260729
DTEND;VALUE=DATE:20260730
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Earnings Call\, FY2026 Q2
DESCRIPTION:The start time has not been announced.\nWebcast: https://invest
 ors.biogen.com/events/event-details/q2-2026-earnings-call-webcast
URL:https://equibles.com/stocks/biib/calls/2026-q2
END:VEVENT
BEGIN:VEVENT
UID:8ccb30c7-4bf4-47d2-abb5-1c9f07a7bfbb@equibles.com
DTSTAMP:20260826T121621Z
DTSTART;VALUE=DATE:20260825
DTEND;VALUE=DATE:20260826
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Participate in the Wells F
 argo 21st Annual Healthcare Conference
DESCRIPTION:Biogen to Participate in the Wells Fargo 21st Annual Healthcare
  Conference\nThe start time has not been announced.\nWebcast: https://inve
 stors.biogen.com/news-releases/news-release-details/biogen-participate-wel
 ls-fargo-21st-annual-healthcare-conference
END:VEVENT
BEGIN:VEVENT
UID:b4071483-ba91-4623-838d-d779aa192e9c@equibles.com
DTSTAMP:20260829T145711Z
DTSTART;VALUE=DATE:20260827
DTEND;VALUE=DATE:20260828
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Participate in the Morgan 
 Stanley 24th Annual Global Healthcare Conference
DESCRIPTION:Biogen to Participate in the Morgan Stanley 24th Annual Global 
 Healthcare Conference\nThe start time has not been announced.\nWebcast: ht
 tps://investors.biogen.com/news-releases/news-release-details/biogen-parti
 cipate-morgan-stanley-24th-annual-global-healthcare
END:VEVENT
BEGIN:VEVENT
UID:ad097b54-d767-4e16-82a3-6942e8bb269f@equibles.com
DTSTAMP:20260901T160952Z
DTSTART;VALUE=DATE:20260901
DTEND;VALUE=DATE:20260902
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Capital Markets Day: Stoke Therapeutics and Biog
 en Announce Presentations of Clinical Data from Studies of Zorevunersen\, 
 an Investigational Medicine for the Treatment of Dravet Syndrome\, at the 
 16th European Epilepsy Congress (EEC)
DESCRIPTION:Stoke Therapeutics and Biogen Announce Presentations of Clinica
 l Data from Studies of Zorevunersen\, an Investigational Medicine for the 
 Treatment of Dravet Syndrome\, at the 16th European Epilepsy Congress (EEC
 )\nThe start time has not been announced.\nWebcast: https://investors.biog
 en.com/news-releases/news-release-details/stoke-therapeutics-and-biogen-an
 nounce-presentations-clinical
END:VEVENT
BEGIN:VEVENT
UID:bc522c1c-abb6-450d-a564-48b2a4a05f53@equibles.com
DTSTAMP:20260826T144647Z
DTSTART:20260909T133000Z
DTEND:20260909T143000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Present at the Wells Fargo
  21st Annual Healthcare Conference
DESCRIPTION:Biogen to Present at the Wells Fargo 21st Annual Healthcare Con
 ference\nWebcast: https://event.summitcast.com/view/aMepMFxWv3z5SRZ9meKJzp
 /RLF6ZfUq6326ybSRScYb5i
URL:https://equibles.com/stocks/biib/events/bc522c1c-abb6-450d-a564-48b2a4a
 05f53
END:VEVENT
BEGIN:VEVENT
UID:538398ed-8767-4540-ba27-d0b1d7d3998f@equibles.com
DTSTAMP:20260829T124232Z
DTSTART:20260914T131500Z
DTEND:20260914T141500Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Present at the Morgan Stan
 ley 24th Annual Global Healthcare Conference
DESCRIPTION:Biogen to Present at the Morgan Stanley 24th Annual Global Heal
 thcare Conference\nWebcast: https://event.webcasts.com/starthere.jsp?ei=17
 73737&tp_key=54e9dde2be&tp_special=8
URL:https://equibles.com/stocks/biib/events/538398ed-8767-4540-ba27-d0b1d7d
 3998f
END:VEVENT
BEGIN:VEVENT
UID:e914899a-2bff-4c7f-9213-51228acfacb8@equibles.com
DTSTAMP:20260917T152144Z
DTSTART:20261028T123000Z
DTEND:20261028T133000Z
SEQUENCE:0
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Earnings Call\, FY2026 Q3
DESCRIPTION:Webcast: https://event.webcasts.com/starthere.jsp?ei=1771787&tp
 _key=52bcd10df0
URL:https://equibles.com/stocks/biib/calls/2026-q3
END:VEVENT
BEGIN:VEVENT
UID:d2276bf3-71d9-4eeb-8d85-507e4a9cac32@equibles.com
DTSTAMP:20261115T020414Z
DTSTART:20261117T133000Z
DTEND:20261117T143000Z
SEQUENCE:27482654
STATUS:CONFIRMED
TRANSP:TRANSPARENT
SUMMARY:Biogen Inc. (BIIB) Conference: Biogen to Present at the Jefferies G
 lobal Healthcare Conference
DESCRIPTION:Biogen to Present at the Jefferies Global Healthcare Conference
 \nWebcast: https://investors.biogen.com/events/event-details/biogen-presen
 t-jefferies-global-healthcare-conference
URL:https://equibles.com/stocks/biib/events/d2276bf3-71d9-4eeb-8d85-507e4a9
 cac32
END:VEVENT
END:VCALENDAR
